Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 726 to 750 of 797

Sort by

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis	TA199	25 August 2010	25 August 2010
Capecitabine for the treatment of advanced gastric cancer	TA191	28 July 2010	28 July 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer	TA192	28 July 2010	28 July 2010
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia	TA193	28 July 2010	28 July 2010
Human growth hormone (somatropin) for the treatment of growth failure in children	TA188	26 May 2010	26 May 2010
Infliximab and adalimumab for the treatment of Crohn's disease	TA187	19 May 2010	19 May 2010
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes	TA47	5 September 2002	1 March 2010
Topotecan for the treatment of relapsed small-cell lung cancer	TA184	25 November 2009	25 November 2009
Topotecan for the treatment of recurrent and stage IVB cervical cancer	TA183	28 October 2009	28 October 2009
Guidance on the use of electroconvulsive therapy	TA59	26 April 2003	1 October 2009
Sunitinib for the treatment of gastrointestinal stromal tumours	TA179	23 September 2009	23 September 2009
Pemetrexed for the first-line treatment of non-small-cell lung cancer	TA181	23 September 2009	23 September 2009
Alitretinoin for the treatment of severe chronic hand eczema	TA177	26 August 2009	26 August 2009
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma	TA178	26 August 2009	26 August 2009
Tenofovir disoproxil for the treatment of chronic hepatitis B	TA173	22 July 2009	22 July 2009
Rituximab for the first-line treatment of chronic lymphocytic leukaemia	TA174	22 July 2009	22 July 2009
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults	TA170	22 April 2009	22 April 2009
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma	TA169	25 March 2009	25 March 2009
Amantadine, oseltamivir and zanamivir for the treatment of influenza	TA168	25 February 2009	25 February 2009
Machine perfusion systems and cold static storage of kidneys from deceased donors	TA165	28 January 2009	28 January 2009
Infliximab for acute exacerbations of ulcerative colitis	TA163	17 December 2008	17 December 2008
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin	TA159	22 October 2008	22 October 2008
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults	TA157	24 September 2008	24 September 2008
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza	TA158	24 September 2008	24 September 2008
Routine antenatal anti-D prophylaxis for women who are rhesus D negative	TA156	27 August 2008	27 August 2008

Results per page

10
25
50
All